The first multiple center prospective study of rhFSH CTP in patients undergoing assisted reproductive technology in China
Abstract We assessed the safety and efficacy of rhFSH-CTP, a novel long-acting FSH agent, in controlled ovarian hyperstimulation for patients undergoing ART. A multi-center, open-label, randomized, positive-control, non-inferiority clinical trial was conducted. The study consisted of a phase III ran...
Saved in:
Main Authors: | Longmei Wu, Huayan Yin, Lingfang Guan, Guanjian Li, Junqiang Zhang, Qunshan Shen, Xiaoqing Ni, Chao Wang, Tianjuan Wang, Hao Geng, Chuan Xu, Yunxia Cao, Xiaojin He, Bing Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86962-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and Clinical Application of Rh Blood Group Bank in the East China Region
by: Jin Y, et al.
Published: (2025-02-01) -
Development of highly bioactive long-acting recombinant porcine FSH for batch production management of sows
by: Jiawei Zhang, et al.
Published: (2025-02-01) -
Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2013-12-01) -
Water Model Study on Alloy Melting and Mixing in RH Refining Process
by: XU Zhibo, et al.
Published: (2025-01-01) -
Synergistic effect of Pd+Rh on the microstructure and oxidation resistance of aluminide coatings
by: Zagula-Yavorska M.
Published: (2023-01-01)